PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy
Marcelo Bonomi, Dukagjin M. Blakaj, Rafi Kabarriti, Kyle Colvett, Vinita Takiar, Matthew Biagioli, Voichita Bar-Ad, Sharad Goyal, Brian Muzyka, Kenneth Niermann, Nacer Abrouk, Bryan Oronsky, Tony Reid, Scott Caroen, Stephen Sonis, David J. Sher
Dive into the research topics of 'PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy'. Together they form a unique fingerprint.